In neuroblastoma, adriamycin (ADR)-mediated induction of the CDK inhibitor P21 is upregulated in the absence of TFAP2E, indicating the implication of TFAP2E and P21 signaling pathway [89]. This evidence concerns the gene CDKN1A and neuroblastoma.